Evidence for Two Modes of Binding of the Negative Allosteric Modulator SB269,652 to the Dopamine D<sub>2</sub> Receptor
SB269,652 has been described as the first negative allosteric modulator (NAM) of the dopamine D<sub>2</sub> receptor (D<sub>2</sub>R), however, the binding mode and allosteric mechanism of action of this ligand remain incompletely understood. SB269,652 comprises an orthosteri...
Main Authors: | Richard Ågren, Kristoffer Sahlholm |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/1/22 |
Similar Items
-
In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators
by: Jiayi Yuan, et al.
Published: (2022-01-01) -
Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase
by: Elisa Rojas-Prats, et al.
Published: (2024-12-01) -
Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics
by: Irene Fasciani, et al.
Published: (2020-11-01) -
Potentiation and allosteric agonist activation of α7 nicotinic acetylcholine receptors: binding sites and hypotheses
by: Victoria R. Sanders, et al.
Published: (2023-05-01) -
RORγ Structural Plasticity and Druggability
by: Mian Huang, et al.
Published: (2020-07-01)